ArticleThe Journal of surgical research2025
Retrospective Cohort Analysis of Outcomes Among Young Onset Breast Cancer Patients in Kijabe, Kenya.
Article in The Journal of surgical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The incidence, clinicopathological characteristics and the survival outcomes among young breast cancer patients in Alexandria, Egypt.Ecancermedicalscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionBreast cancer remains one of the leading causes of morbidity and mortality worldwide, especially for regions of sub-Saharan Africa where little is known about how age of diagnosis relates to breast cancer outcomes. Our study evaluated differences in characteristics and outcomes between those diagnosed with young onset versus average onset breast cancer at a tertiary referral hospital in rural Kenya.
methodsWe performed a retrospective study evaluating breast cancer patients at Kijabe Hospital, dividing cohorts into young (</ = 45 y at diagnosis) and average onset (>45 y). We analyzed tumor characteristics and social factors. Univariate analysis was performed and Cox regression models were fit to analyze the primary outcome of overall survival and secondary outcome of disease-free survival.
resultsThere was no difference when evaluating tumor type (P = 0.06), grade (P = 0.06), hormone receptor positivity (P = 0.29), or metastatic presence (P = 0.27). Patients with early-onset disease were more likely to present with larger tumor size (P < 0.01) and more likely to present with larger nodal burden (P < 0.01). There was no significant difference in overall or disease-free survival between the two groups (P = 0.35 and P = 0.5, respectively).
conclusionsPatients with young onset breast cancer presented with larger tumors and more nodal disease. This suggests delays in presentation, which may be due to gaps in screening, poor education about breast cancer signs, or familial and cultural barriers. Despite this, overall and disease-free survival were not different, suggesting that once diagnosed, younger patients may be treated more aggressively or respond better to treatment. Additional studies are needed to explore these intricacies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.